Urinary MicroRNAs as biomarkers of urological cancers: a systematic review
MicroRNAs (miRNAs) are emerging as biomarkers for the detection and prognosis of
cancers due to their inherent stability and resilience. To summarize the evidence regarding …
cancers due to their inherent stability and resilience. To summarize the evidence regarding …
The miR-200 family of microRNAs: fine tuners of epithelial-mesenchymal transition and circulating cancer biomarkers
Simple Summary MicroRNAs (miRNAs) are small RNA molecules that regulate gene
expression by blocking translation or inducing degradation of specific gene transcripts. The …
expression by blocking translation or inducing degradation of specific gene transcripts. The …
Noncoding RNAs in extracellular fluids as cancer biomarkers: the new frontier of liquid biopsies
The last two decades of cancer research have been devoted in two directions:(1)
understanding the mechanism of carcinogenesis for an effective treatment, and (2) …
understanding the mechanism of carcinogenesis for an effective treatment, and (2) …
Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin …
G Shan, X Zhou, J Gu, D Zhou, W Cheng, H Wu… - Cellular Oncology, 2021 - Springer
Objective Exosomes derived from cancer-associated fibroblasts (CAFs) are known as
important drivers of tumor progression. Previously, microRNA (miR)-148b-3p has been …
important drivers of tumor progression. Previously, microRNA (miR)-148b-3p has been …
SERS liquid biopsy: An emerging tool for medical diagnosis
V Moisoiu, SD Iancu, A Stefancu, T Moisoiu… - Colloids and Surfaces B …, 2021 - Elsevier
Surface-enhanced Raman scattering (SERS) is emerging as a novel strategy for biofluid
analysis. In this review, we delineate four experimental SERS protocols that are frequently …
analysis. In this review, we delineate four experimental SERS protocols that are frequently …
Role of exosomal miRNA in bladder cancer: a promising liquid biopsy biomarker
Bladder cancer (BCa) is the most prevalent neoplasia of the urinary tract. Unfortunately,
limited improvements in effective BCa management have meant that it remains a …
limited improvements in effective BCa management have meant that it remains a …
Urinary markers in bladder cancer: an update
G Santoni, MB Morelli, C Amantini, N Battelli - Frontiers in oncology, 2018 - frontiersin.org
Bladder cancer (BC) is ones of the most common cancer worldwide. It is classified in muscle
invasive (MIBC) and muscle non-invasive (NMIBC) BC. NMIBCs frequently recur and …
invasive (MIBC) and muscle non-invasive (NMIBC) BC. NMIBCs frequently recur and …
Detection of bladder cancer using urinary cell-free DNA and cellular DNA
Z Ou, K Li, T Yang, Y Dai, M Chandra, J Ning… - Clinical and …, 2020 - Springer
Background The present study sought to identify a panel of DNA markers for noninvasive
diagnosis using cell-free DNA (cfDNA) from urine supernatant or cellular DNA from urine …
diagnosis using cell-free DNA (cfDNA) from urine supernatant or cellular DNA from urine …
Liquid biopsy biomarkers in bladder cancer: a current need for patient diagnosis and monitoring
I Lodewijk, M Dueñas, C Rubio… - International journal of …, 2018 - mdpi.com
Bladder Cancer (BC) represents a clinical and social challenge due to its high incidence
and recurrence rates, as well as the limited advances in effective disease management …
and recurrence rates, as well as the limited advances in effective disease management …
Small non-coding RNA profiling in plasma extracellular vesicles of bladder cancer patients by next-generation sequencing: expression levels of miR-126-3p and piR …
Bladder cancer (BC) is the tenth most frequent cancer worldwide. Due to the need for
recurrent cystoscopies and the lack of non-invasive biomarkers, BC is associated with a high …
recurrent cystoscopies and the lack of non-invasive biomarkers, BC is associated with a high …